| |
|
|
|
Forward Pharma ADR  
|
|
6.75 0.37 (0.06%) |
09-28 16:00 |
|
Open: |
6.53 |
Pre close: |
6.38 |
Target:
|
9.60
|
|
High: |
6.85 |
Low: |
6.28 |
Resistance:
|
8.22
9.74
|
|
Volume: |
119,438 |
Market Cap: |
47M |
Support:
|
5.77
4.80
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.56
 |
MACD |
MACD(12,26):
|
-0.51 |
|
MA(20): |
6.76  |
Signal(12,26,9): |
-0.65 |
|
MA(100): |
8.34 |
Stochastic Oscillator |
%K(14,3):
|
29.63 |
|
MA(250): |
7.56 |
%D(3): |
25.04 |
|
Average Volume(K) |
3-Month: |
847778
|
52-Week |
High:
|
20.31 |
|
10-Days: |
9987 |
Low: |
5.77 |
|
RSI |
RSI(14):
|
44.63 |
Change(%): |
8.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.980 |
Return on Equity (ttm) |
-8.3 |
Shares Out. (M) |
7.02 |
|
EPS Est. Current Year |
2.490 |
Return on Assets (ttm) |
-2.7 |
Shares Float (M) |
1.39 |
|
EPS Est. Next Year |
-0.090 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.830 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
14.03 |
|
Forward EPS |
-0.090 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
5 |
|
Book Value (p.s.) |
11.410 |
EBITDA (p.s.) |
-0.481 |
P/E |
-6.89 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.59 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.71 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-1.43 |
P/CF |
-8.30 |
|
|
|
|
|
|
